Offer - Urjas Oil for just ₹ 1 X
Gatiflo (Synchem) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Conjunctivitis. Other than this, Gatiflo (Synchem) has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Gatiflo (Synchem) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Gatiflo (Synchem) also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Dizziness. While these are the most often observed Gatiflo (Synchem) side effects, there are can be others also. These have been listed below. Such side effects of Gatiflo (Synchem) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Gatiflo (Synchem) has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Gatiflo (Synchem)'s effects on the liver, heart and kidney, if any, have been listed below.
Gatiflo (Synchem) is contraindicated in people with pre-existing medical conditions like Myasthenia Gravis (MG), Brain and Nervous System, Tendon Injury (Tendinopathy) as it can result in adverse effects. Some other conditions that can be affected by Gatiflo (Synchem) are listed in the contraindications section below.
Drug reaction of Gatiflo (Synchem) with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Gatiflo (Synchem), it is important to know that it is safe while driving, and is habit-forming.
Gatiflo (Synchem) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gatiflo (Synchem) safe for pregnant women?
Gatiflo (Synchem) may have some side effects during pregnancy. Pregnant women should discontinue the use of Gatiflo (Synchem), and talk to their doctor, if they notice any discomfort.
Is the use of Gatiflo (Synchem) safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Gatiflo (Synchem). It should only be taken after medical advice.
What is the effect of Gatiflo (Synchem) on the Kidneys?
Gatiflo (Synchem) is not harmful for kidneys.
What is the effect of Gatiflo (Synchem) on the Liver?
Gatiflo (Synchem) is not harmful for the liver.
What is the effect of Gatiflo (Synchem) on the Heart?
Gatiflo (Synchem) is not harmful for the heart.
Gatiflo (Synchem) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gatiflo (Synchem) unless your doctor advises you to do so -
Is this Gatiflo (Synchem) habit forming or addictive?
No, there is no any evidence that Gatiflo (Synchem) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Gatiflo (Synchem) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Taking Gatiflo (Synchem) may cause some problems.
Is it able to treat mental disorders?
There is no benefit of taking Gatiflo (Synchem) for mental disorders.
Interaction between Food and Gatiflo (Synchem)
Gatiflo (Synchem) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Gatiflo (Synchem)
Information about the interaction of Gatiflo (Synchem) and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZymaxidY™ (gatifloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399